Baclofen Abuse due to Its Hypomanic Effect in Patients with Alcohol Dependence and Comorbid Major Depressive Disorder
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Baclofen is a gamma-aminobutyric acid type B receptor agonist used as an anti-craving agent for treatment of alcohol dependence. It has gained popularity in the recent times because it is well tolerated even in patients with hepatic impairments. Herein we are summarizing the latest literature about baclofen induced hypomania and are reporting a case of baclofen abuse because of its mood elevating property in a patient of alcohol dependence with comorbid major depressive disorder. Literature review and case study of a 36-year-old male with alcohol dependence with comorbid major depressive disorder was prescribed with tablet baclofen as an anti-craving agent along with antidepressant medicines. The patients who did not improve with conventional antidepressant therapy started feeling better in terms of his mood symptoms on taking tablet baclofen. Owing to the mood elevating property he started abusing baclofen. Despite its safety profile in hepatic impairment, one must be very cautious in prescribing baclofen because of its mood altering property which may account for its abuse potentiality.
Abstract
Baclofen is a gamma-aminobutyric acid type B receptor agonist used as an anti-craving agent for treatment of alcohol dependence. It has gained popularity in the recent times because it is well tolerated even in patients with hepatic impairments. Herein we are summarizing the latest literature about baclofen induced hypomania and are reporting a case of baclofen abuse because of its mood elevating property in a patient of alcohol dependence with comorbid major depressive disorder. Literature review and case study of a 36-year-old male with alcohol dependence with comorbid major depressive disorder was prescribed with tablet baclofen as an anti-craving agent along with antidepressant medicines. The patients who did not improve with conventional antidepressant therapy started feeling better in terms of his mood symptoms on taking tablet baclofen. Owing to the mood elevating property he started abusing baclofen. Despite its safety profile in hepatic impairment, one must be very cautious in prescribing baclofen because of its mood altering property which may account for its abuse potentiality.
참고문헌 (15)
- Geoffroy PA, "Baclofen-induced manic symptoms : case report and systematic review", Psychosomatics, 55, pp.326~332 (2014)
- Silva JV, "Baclofen-induced manic episode - a case report", IJCNMH, (2 Suppl 1), pp.P59~ (2015)
- Addolorato G, "Baclofen efficacy in reducing alcohol craving and intake : a preliminary double-blind randomized controlled study", Alcohol Alcohol, 37, pp.504~508 (2002)
- Colombo G, "Role of GABA(B)receptor in alcohol dependence : reducing effect of baclofen on alcohol intake and alcohol motivational properties in rats and amelioration of alcohol withdrawal syndrome and alcohol craving in human alcoholics", Neurotox Res, 6, pp.403~414 (2004)
- Addolorato G, "Baclofen Study Group. Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, doubleblind, placebo-controlled trial", Alcohol Alcohol, 46, pp.312~317 (2011)
- Ameisen O, "Complete and prolonged suppression of symptoms and consequences of alcohol-dependence using highdose baclofen : a self-case report of a physician", Alcohol Alcohol, 40, pp.147~150 (2005)
- Bucknam W, "Suppression of symptoms of alcohol dependence and craving using high-dose baclofen", Alcohol Alcohol, 42, pp.158~160 (2007)
- Franchitto N, "Self-intoxication with baclofen in alcohol-dependent patients with co-existing psychiatric illness : an emergency department case series", Alcohol Alcohol, 49, pp.79~83 (2014)
- Pommier P, "Severity of deliberate acute baclofen poisoning : a nonconcurrent cohort study", Basic Clin Pharmacol Toxicol, 114, pp.360~364 (2014)
- Lee TH, "Baclofen intoxication : report of four cases and review of the literature", Clin Neuropharmacol, 15, pp.56~62 (1992)
- Rolland B, "Assessing alcohol versus baclofen withdrawal syndrome in patients treated with baclofen for alcohol use disorder", J Clin Psychopharmacol, 34, pp.153~156 (2014)
- Bartholini G, "GABA receptor agonists : pharmacological spectrum and therapeutic actions", Med Res Rev, 5, pp.55~75 (1985)
- Angst J, "The HCL-32 : towards a self-assessment tool for hypomanic symptoms in outpatients", J Affect Disord, 88, pp.217~233 (2005)
- Naranjo CA, "A method for estimating the probability of adverse drug reactions", Clin Pharmacol Ther, 30, pp.239~245 (1981)
- Zaki SA, "Adverse drug reaction and causality assessment scales", Lung India, 28, pp.152~153 (2011)